Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high26.62 25/05/17
52 week low15.35 15/12/17
52 week change -1.13 (-6.81%)
4 week volume5,653,007 20/11/17

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
06/07/2015
Presenter: Kieron Harbinson, Group Finance Director
14/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - finnCap issues a broker note on Omega Diagnostics Group PLC

finnCap today reaffirms its corporate investment rating on Omega Diagnostics Group PLC (LON:ODX) and cut its price t...

Omega CEO steps down

Omega Diagnostics' Andrew Shepherd has agreed to step down as chief executive officer and from the board with immed...

Omega revenue up 4%

Omega Diagnostics, the medical diagnostics, increased its revenue by 4% to 7.11m in the six months ended 30 September. Foo...

CEO succession

RNS Number: 3006Z Omega Diagnostics Group PLC 14 December 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") CEO succession Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that as part of Omega's Board succession planning, Andrew Shepherd has agreed to step down...

Interim results

RNS Number: 3004Z Omega Diagnostics Group PLC 14 December 2017 OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group") INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2017 Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces its un...

VISITECT? CD4 CE-Mark

RNS Number: 7714X Omega Diagnostics Group PLC 29 November 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") VISITECT CD4 CE-Mark Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its VISITECT CD4 test for helping to manage people living...

Change of Registered Office

RNS Number: 0827V Omega Diagnostics Group PLC 01 November 2017 Omega Diagnostics Group PLC ("Omega" or "the Company") Change of Registered Office Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that with immediate effect, the registered office of the Company has been cha...

Omega Diagnostics expects 4% revenue rise

Omega Diagnostics Group said it expects first-half revenue to increase by 4% to 7.11m on-year. In constant currency terms, ...

Fundamental DataMore

P/E ratio22.143
EPS0.7
Dividend yield0 %

Latest discussion posts More

  • Re: Great tip disorder

    Hmmmmmm.. As already stated.. Out with the old and in with the new. New guys always want to get all bad, news out. It then provides them a base from which to build, but ...
    15-Dec-2017
    Disorder
  • Re: immunodiagnostic holdings reading be...

    Re the fall in share price to below the offer price. A new CEO airs the dirty washing to establish a low baseline from which to move forward. Read the last IDH report their ...
    14-Dec-2017
    mnbvvvvvvvvvvvcxz
  • Re: immunodiagnostic holdings reading betwee...

    Yes I think you may well be right mnbv etc. I think some will say that both Omega and IDS need better strategic thinking and commercial focus and replacing CEOs may achieve ...
    14-Dec-2017
    pharmaspecialist

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account